$SNDX

$13.98▲ -17.6% YTD

5 SEC 13D/G filings tracked · Last updated Oct 12, 2026

Filing History

SNDX ▼ -17.6% - Syndax Pharmaceuticals, Inc.

CP $13.98▲ -17.6%Oct 12, 2026 · ThinkSabio Blog

$SNDX - Syndax Announces Topline Results from MAXPIRe Phase 2 Trial of Axatilimab in Idiopathic Pulmonary Fibrosis…

SNDX ▼ -3.4% - Syndax Pharmaceuticals, Inc.

CP $17.60▲ -3.4%Oct 2, 2026 · ThinkSabio Blog

$SNDX - Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)…

SNDX ▼ -0.7% - Syndax Pharmaceuticals, Inc.

CP $20.56▲ -0.7%Sep 4, 2026 · ThinkSabio Blog

$SNDX - Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)…

SNDX ▼ -0.3% - Syndax Pharmaceuticals, Inc.

CP $19.29▲ -0.3%Sep 1, 2026 · ThinkSabio Blog

$SNDX - Syndax Announces Participation in September Investor Conferences…

SNDX - Syndax Pharmaceuticals, Inc. - SEC Filing Update (07-AUG-2026) | ThinkSabio - Stocks Simplified

$19.92▼ -6.48%Aug 7, 2026 · ThinkSabio Blog

$SNDX SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #SNDX Syndax Pharmaceuticals, Inc. : $19.92 Sector: Healthcare |…